Autopsy report · NCT03040024

Delirium Prevention With Ketamine in Ear, Nose, and Throat (ENT) Patients

“Halted due to COVID 19; we believe we have adequate data for analysis”

The sponsor’s own words in the registry.

Life of this trial

• Registered 2 months before it started.
• Ran for about 3 years 1 month before it stopped.
• 71 participants enrolled.
• Results were posted on the registry 11 months after it ended.

Vital statistics

Status

Terminated

Phase

Phase 4

Sponsor

Emory University

Sponsor type

University, hospital or other

Conditions

Otolaryngeal Cancer

Interventions

Ketamine; Placebo; Electroencephalogram (EEG)

Participants

71

Sites

1

Countries

United States

Trials that died the same way

• RAman For Thyroid cancER
  “Covid19 halted study” (78% match in meaning)
• A Multilevel Intervention in the Hunger Relief Network to Improve Diet Among Adults Experiencing Food Insecurity
  “Data collection was halted prematurely due to COVID-19.” (73% match in meaning)
• Effects of Short-term Choir Participation on Auditory Perception in Hearing-aided Older Adults.
  “COVID-19 forced the shut down of the study” (73% match in meaning)
• RES Prepared With RECELL® Compared to Conventional Care for Healing of Donor Sites in Ages 1-16 Years
  “Study closed in response to COVID-19 and overall program objectives.” (73% match in meaning)
• Physiological Effects of 38°C vs. 22°C Fluid Therapy in Critically Ill Patients
  “Other research priorities during Covid-19 pandemic.” (73% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.